These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

566 related articles for article (PubMed ID: 17008837)

  • 1. Cirrhotic portal hypertension: current and future medical therapy for primary and secondary prevention of variceal bleeding.
    Laleman W; Nevens F
    Minerva Med; 2006 Aug; 97(4):325-45. PubMed ID: 17008837
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The sixth Carlos E. Rubio Memorial Lecture. Prevention and treatment of variceal hemorrhage.
    Bosch J
    P R Health Sci J; 2000 Mar; 19(1):57-67. PubMed ID: 10761206
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Prevention of Rebleeding From Esophageal Varices in Patients With Cirrhosis Receiving Small-Diameter Stents Versus Hemodynamically Controlled Medical Therapy.
    Sauerbruch T; Mengel M; Dollinger M; Zipprich A; Rössle M; Panther E; Wiest R; Caca K; Hoffmeister A; Lutz H; Schoo R; Lorenzen H; Trebicka J; Appenrodt B; Schepke M; Fimmers R;
    Gastroenterology; 2015 Sep; 149(3):660-8.e1. PubMed ID: 25989386
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prevention of recurrent esophageal variceal hemorrhage: review and current recommendations.
    Kravetz D
    J Clin Gastroenterol; 2007; 41 Suppl 3():S318-22. PubMed ID: 17975483
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Endoscopic ligation compared with combined treatment with nadolol and isosorbide mononitrate to prevent recurrent variceal bleeding.
    Villanueva C; Miñana J; Ortiz J; Gallego A; Soriano G; Torras X; Sáinz S; Boadas J; Cussó X; Guarner C; Balanzó J
    N Engl J Med; 2001 Aug; 345(9):647-55. PubMed ID: 11547718
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Long-term results of a clinical trial of nadolol with or without isosorbide mononitrate for primary prophylaxis of variceal bleeding in cirrhosis.
    Merkel C; Marin R; Sacerdoti D; Donada C; Cavallarin G; Torboli P; Amodio P; Sebastianelli G; Bolognesi M; Felder M; Mazzaro C; Gatta A
    Hepatology; 2000 Feb; 31(2):324-9. PubMed ID: 10655253
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Combined therapy for secondary prophylaxis of variceal rebleeding?
    Maldonado D; Barkin JS
    Am J Gastroenterol; 2002 Aug; 97(8):2134-6. PubMed ID: 12190191
    [No Abstract]   [Full Text] [Related]  

  • 8. Portal hypertension: from pathophysiology to clinical practice.
    Laleman W; Landeghem L; Wilmer A; Fevery J; Nevens F
    Liver Int; 2005 Dec; 25(6):1079-90. PubMed ID: 16343056
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Importance of drug treatment to lower portal pressure in the therapy of variceal bleeding].
    Schepke M
    Dtsch Med Wochenschr; 2009 Sep; 134(37):1823-7. PubMed ID: 19728251
    [No Abstract]   [Full Text] [Related]  

  • 10. Randomised trial of nadolol alone or with isosorbide mononitrate for primary prophylaxis of variceal bleeding in cirrhosis. Gruppo-Triveneto per L'ipertensione portale (GTIP).
    Merkel C; Marin R; Enzo E; Donada C; Cavallarin G; Torboli P; Amodio P; Sebastianelli G; Sacerdoti D; Felder M; Mazzaro C; Beltrame P; Gatta A
    Lancet; 1996 Dec 21-28; 348(9043):1677-81. PubMed ID: 8973428
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The hemodynamic response to medical treatment of portal hypertension as a predictor of clinical effectiveness in the primary prophylaxis of variceal bleeding in cirrhosis.
    Merkel C; Bolognesi M; Sacerdoti D; Bombonato G; Bellini B; Bighin R; Gatta A
    Hepatology; 2000 Nov; 32(5):930-4. PubMed ID: 11050041
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prevention and treatment of variceal haemorrhage in 2017.
    Brunner F; Berzigotti A; Bosch J
    Liver Int; 2017 Jan; 37 Suppl 1():104-115. PubMed ID: 28052623
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pharmacologic prevention of variceal bleeding and rebleeding.
    Baiges A; Hernández-Gea V; Bosch J
    Hepatol Int; 2018 Feb; 12(Suppl 1):68-80. PubMed ID: 29210030
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Evaluation of endoscopic variceal ligation (EVL) versus propanolol plus isosorbide mononitrate/nadolol (ISMN) in the prevention of variceal rebleeding: comparison of cirrhotic and noncirrhotic patients.
    Sarin SK; Wadhawan M; Gupta R; Shahi H
    Dig Dis Sci; 2005 Aug; 50(8):1538-47. PubMed ID: 16110851
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Randomized, controlled trial of carvedilol versus nadolol plus isosorbide mononitrate for the prevention of variceal rebleeding.
    Lo GH; Chen WC; Wang HM; Yu HC
    J Gastroenterol Hepatol; 2012 Nov; 27(11):1681-7. PubMed ID: 22849337
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Covered TIPS versus endoscopic band ligation plus propranolol for the prevention of variceal rebleeding in cirrhotic patients with portal vein thrombosis: a randomised controlled trial.
    Lv Y; Qi X; He C; Wang Z; Yin Z; Niu J; Guo W; Bai W; Zhang H; Xie H; Yao L; Wang J; Li T; Wang Q; Chen H; Liu H; Wang E; Xia D; Luo B; Li X; Yuan J; Han N; Zhu Y; Xia J; Cai H; Yang Z; Wu K; Fan D; Han G;
    Gut; 2018 Dec; 67(12):2156-2168. PubMed ID: 28970291
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Secondary prophylaxis of variceal bleeding for cirrhotic patients: a multiple-treatments meta-analysis.
    Shi KQ; Liu WY; Pan ZZ; Ling XF; Chen SL; Chen YP; Fan YC; Zheng MH
    Eur J Clin Invest; 2013 Aug; 43(8):844-54. PubMed ID: 23725530
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Addition of propranolol and isosorbide mononitrate to endoscopic variceal ligation does not reduce variceal rebleeding incidence.
    Kumar A; Jha SK; Sharma P; Dubey S; Tyagi P; Sharma BC; Sarin SK
    Gastroenterology; 2009 Sep; 137(3):892-901, 901.e1. PubMed ID: 19481079
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Primary prophylaxis of variceal bleeding.
    Thuluvath PJ; Krishnan A
    Gastrointest Endosc; 2003 Oct; 58(4):558-67. PubMed ID: 14520290
    [No Abstract]   [Full Text] [Related]  

  • 20. The role of transjugular intrahepatic portosystemic shunt (TIPS) in the management of portal hypertension.
    Colombato L
    J Clin Gastroenterol; 2007; 41 Suppl 3():S344-51. PubMed ID: 17975487
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 29.